Pfizer forecasts 24% covid vaccination rate in US this year.
Back in the summer of 2021, when the Biden administration continued to hype the hazards associated with COVID-19, I looked at the history of a seemingly similar virus that caused the “Russian Flu.” Based on that information, I concluded:
In a nutshell, the Russian flu evolved from a serious pathogen into another common cold virus. A glance at the number of deaths associated with COVID-19 within this country indicates that this virus appears to be trending in the same direction.
As the prophecy foretold:
Doctors say they’re finding it increasingly difficult to distinguish Covid from allergies or the common cold, even as hospitalizations tick up.
The illness’ past hallmarks, such as a dry cough or the loss of sense of taste or smell, have become less common. Instead, doctors are observing milder disease, mostly concentrated in the upper respiratory tract.
“It isn’t the same typical symptoms that we were seeing before. It’s a lot of congestion, sometimes sneezing, usually a mild sore throat,” said Dr. Erick Eiting, vice chair of operations for emergency medicine at Mount Sinai Downtown in New York City.
I will note that my prediction came before the Biden vaccine mandate and the endless booster campaigns.
With all of this in mind, it should come as no surprise to anyone with common sense that Americans are becoming increasingly less likely to get the booster shots our public health professionals and pharmaceutical industry experts continue to promote.
Pfizer (PFE.N) expects 24% of the U.S. population, or about 82 million people, to receive COVID-19 shots this year, CFO David Denton said at a conference on Monday, reiterating the vaccine maker’s estimates from earlier this year.
The U.S. Food and Drug Administration has authorized updated COVID vaccines from Pfizer and its partner BioNTech (22UAy.DE), as well as from Moderna, as the country prepares to start a fall vaccination campaign. A third vaccine from Novavax (NVAX.O) is also under review.
During the last re-vaccination campaign, when most Americans had either already had the COVID virus or been previously vaccinated, only around 56.5 million people got the updated booster shots, according to federal data.
…Pfizer had said in August it will launch a cost-cutting program if its COVID vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand.
Information on test data utilized for current vaccine approval will not likely inspire Americans to get the shot.
Pfizer’s version, approved this week as well, also has zero efficacy data and has not been tested on humans at all. We only have data about antibody production from 10 mice.
Despite these developments, the Biden administration continues to support money-wasting policies and rules that are now senseless. For example, it plans to provide free COVID test kits.
The Biden administration is preparing to resume taking orders for free at-home COVID-19 tests starting September 25, officials announced Wednesday. The administration is also planning a new infusion of money to boost domestic manufacturing of the test kits.
Four free tests will be available for each household to request through the government’s COVIDTests.gov portal beginning on Monday, Sept. 25
Tests will be shipped through the U.S. Postal Service starting Oct. 2, and would not be directly affected by a potential government shutdown if Congress fails to pass a funding bill by the end of the month.
Of course, will these tests really be “free”?
Definitely not free, just what’s $33T in debt?
— Brett (@Texan__Pride) September 20, 2023
I am sick of this administration wasting money. No one is testing if they have basic cold like symptoms. Of course this means no one will take Pfizermectin, which is the real reason these tests are being sent… https://t.co/Co5ez1HrPZ
— Stacey (@ScotsFyre) September 21, 2023
It appears our bureaucratic class is in too deep with its covid policies to reverse course. In fact, the new director of the Centers for Disease Control and Prevention is under the impression their agency will be trusted again.
Mandy Cohen wants to win back America’s trust.
The new CDC director spent her first two months on the job telling audiences in New York, Wisconsin and Washington state the agency has made mistakes, a mea culpa of sorts meant to show that she understands past shortcomings.
“Trust is easily broken and, as folks know, trust takes time to rebuild,” Cohen told POLITICO. “It isn’t something you can fix overnight. I know that this is a long-term way of thinking about it.”
Many Americans have offered sensible suggestions that the CDC can follow to regain that trust:
The CDC wants our trust back.
Good luck with that. A few suggestions:
1/ Treat us like adults, not children who you scold when they are bad. Treat us like human beings not inputs in a model.
2/ Nuance. Not every set of rules should reflect black & white thinking because you… pic.twitter.com/LXLc49pTtP
— Jennifer Sey (@JenniferSey) September 18, 2023
However, I suspect the chances of CDC officials doing any of these actions are about the same as the chances of me getting a covid booster shot: Somewhere between minuscule and infinitesimal.DONATE
Donations tax deductible
to the full extent allowed by law.